The effects of TZDs on insulin secretion and glucose-stimulated insulin secretion
Model . | Plasma . | . | Insulin secretion . | Glucose-stimulated insulin secretion . | Reference . | |
---|---|---|---|---|---|---|
. | Glucose . | Insulin . | . | . | . | |
HIT-T15 cells | Increased insulin secretion in 11 mmol/l glucose | 38 | ||||
Primary islets from humans | No change | No change | 30 | |||
Primary islets from ZDF rats | Decrease | Increase | 39 | |||
Type 2 diabetic humans | Decrease | Decrease | Decrease | Increase | 4 | |
db/db mice | Decrease | Increase* | Increased intracellular insulin content of β-cells | 35 | ||
db/db mice | Decrease | No change | Increased intracellular insulin content of β-cells | 37 | ||
ob/ob mice | Decrease | Decrease | Increase | 34 | ||
KK mice | Decrease | Decrease | Increase | 34 | ||
ZDF rats | Decrease | Decrease | Decrease, increased insulin transcription | Increase | 5,33,34,36,40 |
Model . | Plasma . | . | Insulin secretion . | Glucose-stimulated insulin secretion . | Reference . | |
---|---|---|---|---|---|---|
. | Glucose . | Insulin . | . | . | . | |
HIT-T15 cells | Increased insulin secretion in 11 mmol/l glucose | 38 | ||||
Primary islets from humans | No change | No change | 30 | |||
Primary islets from ZDF rats | Decrease | Increase | 39 | |||
Type 2 diabetic humans | Decrease | Decrease | Decrease | Increase | 4 | |
db/db mice | Decrease | Increase* | Increased intracellular insulin content of β-cells | 35 | ||
db/db mice | Decrease | No change | Increased intracellular insulin content of β-cells | 37 | ||
ob/ob mice | Decrease | Decrease | Increase | 34 | ||
KK mice | Decrease | Decrease | Increase | 34 | ||
ZDF rats | Decrease | Decrease | Decrease, increased insulin transcription | Increase | 5,33,34,36,40 |
NS.